The Medical University of South Carolina   Medical Center  ·  College of Medicine ·  Directory   
Department of Pathology Banner MUSC Logo


Our Mission

To serve patients, health care providers, research scientists, scholars, and society by providing excellence and innovation in diagnostic services and educational resources in a respectful, professional and culturally diverse atmosphere.

Our Vision

To become a preeminent leader in academic anatomic and clinical pathology while translating basic science discovery to improved clinical care.



David Turner, PhD

David Turner, Ph.D.

Assistant Professor, Department of Pathology and Laboratory Medicine
Director of shRNA Technology Shared Resource
The James E. Clyburn Research Center
Medical University of South Carolina
68 President Street
Charleston, SC 29425
Office: BE407
Phone: (843) 876-2377
Laboratory: BE428
Lab Phone: (843) 876-2309

Visit Dr. Turner's Laboratory

EDUCATION:

Bsc (Hons) in Molecular Biology: 1993-1996, University of Newcastle Upon Tyne, England, UK.
Ph.D. in Biochemistry: 1997-2001, University of Newcastle Upon Tyne, England, UK.
Post-Doctoral Fellowship: 2001-2002, University of Newcastle Upon Tyne, England, UK.
Post-Doctoral Fellowship: 2002-2004, Fox Chase Cancer Center, Philadelphia, PA, USA.
Post-Doctoral Fellowship: 2004-2008, Medical University of South Carolina, Charleston, SC, USA

Employment:

Research Assistant Professor: 2008-Present, Medical University of South Carolina, Charleston, SC, USA.
Director of shRNA Shared Technology Resource, Medical University of South Carolina, Charleston, SC, USA.

RESEARCH INTERESTS:

Trans-disciplinary research into the links between the social and environmental determinants of health disparities and cancer biology.
Mechanistic effects of lifestyle intervention on cancer biological pathways promoting cancer and cancer recurrence.
The identification and development of potential biomarkers and novel therapeutic targets for the treatment of cancer.

SELECTED PUBLICATIONS:

  1. Francis M. Hughes, Jr., David P. Turner and J. Todd Purves. Potential Repertoire of the Innate Immune System in the Bladder: Expression of Pattern Recognition Receptors in the Rat Bladder and a Rat Urothelial Cell Line (MYP3 cells). Submitted to Urology, Jan 2015.
  2. Lindsay T. McDonald; Dayvia A. Laws; Ryan R. Kelly; Ying Xiong; Risha K. Patel; Jeffrey A. Jones; Patricia M. Watson; David P. Turner; Dennis K. Watson; Victoria J. Findlay; Amanda C. LaRue, Ph.D. Hematopoietic Stem Cell-Derived Cancer-Associated Fibroblasts are Novel Contributors to the Pro-Tumorigenic Microenvironment. Submitted to Neoplasia, Jan. 2015.
  3. Turner D.P. Advanced glycation end-products: A biological consequence of lifestyle contributing to cancer disparity. In Press, Cancer Research. (Invited Review)
  4. Foster D, Spruill L, Walter KR, Nogueira LM, Fedarovich H, Turner, RY, Ahmed M, Salley JD, Ford ME, Findlay VJ and Turner DP. Advanced glycation end products are increased in prostate cancer and may promote cancer disparity. CEBP, Oct 2014, 23:2186. PMID. 25053712
  5. Woolworth JA, Halushka PV, Shao Y, Turner DP, Smith MT, Watson DK and Moussa O. Promotion of Cell Migration and Invasion of Blasser Cancer Cells by Thromboxane receptor (TP) Signaling via Ga12. Submitted to Oncogene.
  6. Guo QJ, Mills JN, Bandurraga SG, Nogueira LM, Mason NJ, Camp ER, LaRue AC, Turner DP and Findlay VJ. MicroRNA 510 promotes cell and tumor growth by targeting peroxiredoxin 1 in breast cancer. Breast Cancer Research 15 (4):R70, 2013., PMID: 23971998
  7. Findlay VJ, LaRue AC, Turner DP, Watson PM, Watson DK. Understanding the role of ETS-mediated gene regulation in complex biological processes. 2013, Adv Cancer Res; 119:1-61., PMID: 23870508
  8. Ford ME, Wahlquist AH, Blake R, Green C, Streets J, Fuller EM, Johnson ER, Jefferson MS, Etheredge JW, Varner H, Johnson S, Glover SH, Turner DP, Garrett-Mayer E. Assessing an intervention to improve clinical trial perceptions among predominantly African American


Carroll A. Campbell, Jr. Neuropathology Laboratory (Brain Bank)

Department of Pathology and Laboratory Medicine Chairman Dr. Steven L. Carroll
Message from the Chairman


News


Upcoming Events


Copyright 2011 MUSC Department of Pathology and Laboratory Medicine